Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors
Basic & Clinical Pharmacology & Toxicology · 2026-10 · 139 (4)
DOI: 10.1111/bcpt.70281 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 10.09.2026. Verfasst von Emilia L Bialek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Chemokines, Inflammation, Ticks. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fonds Wetenschappelijk Onderzoek, KU Leuven, Global PhD Partnerships between KU Leuven and Maastricht University.
Abstract (Originalsprache)
Ticks are haematophagous parasites that rely on uninterrupted bloodmeals for survival and need an effective strategy to suppress the host inflammatory response. Leukocyte recruitment is a chemokine‐mediated hallmark of inflammation, which ticks counteract via anti‐chemokine proteins in their saliva named evasins. They are a heterogeneous family of glycoproteins that redundantly bind and inhibit chemokines. We provide a detailed overview of their chemokine‐binding properties, as well as their therapeutic efficacy in models of inflammation in vivo. Moreover, we discuss the potential challenges posed by using evasins in a therapeutic setting and explore how the development of modified evasins might aid this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Immunology, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
- Department of Biochemistry (CARIM), Maastricht University, Maastricht, the Netherlands.
- Department of Radiology and Nuclear Medicine, Maastricht UMC+, Maastricht, the Netherlands.
ORCID-Profile: Pedro E Marques
Förderung
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Global PhD Partnerships between KU Leuven and Maastricht University
Zitieren
APA
Bialek, E. L., Buds, R., Dijkgraaf, I., & Marques, P. E. (2026). Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology, 139(4). https://doi.org/10.1111/bcpt.70281
Vancouver
Bialek EL, Buds R, Dijkgraaf I, Marques PE. Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors. Basic & Clinical Pharmacology & Toxicology. 2026;139(4). doi:10.1111/bcpt.70281
BibTeX
@article{Bialek2026,
author = {Bialek, Emilia L and Buds, Roos and Dijkgraaf, Ingrid and Marques, Pedro E},
title = {Evasins: Biology and Therapeutic Potential of Broad‐Spectrum Chemokine Inhibitors},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {4},
doi = {10.1111/bcpt.70281}
}
EUVIMED